𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome

✍ Scribed by Bertolasi, Laura; Frasson, Emma; Turri, Mara; Gajofatto, Alberto; Bordignon, Monia; Zanolin, Elisabetta; Martini, Millo; Pimazzoni, Fabiana; Ferlisi, Monica; Zanusso, Gianluigi; Rossi, Massimo; Monaco, Salvatore

Book ID
123354986
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
353 KB
Volume
330
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized controlled trial of modafinil
Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients
✍ K. Ming Chan; Fay J. Strohschein; David Rydz; Amyn Allidina; Ashfaq Shuaib; Chri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract The purpose of this study was to test whether modafinil is effective in alleviating the symptoms of fatigue in postpolio patients, because it has been helpful for such symptoms in other neurologic disorders. Using a double‐blind, randomized, placebo‐controlled cross‐over design, 14 post

Progressive resistance training in patie
Progressive resistance training in patients with shoulder impingement syndrome: A randomized controlled trial
✍ Lombardi, Império ;Magri, Ângela Guarnieri ;Fleury, Anna Maria ;Da Silva, Antoni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 3 views

## Abstract ## Objective To assess pain, function, quality of life, and muscle strength in patients with shoulder impingement syndrome who participated in muscle strengthening exercises. ## Methods A total of 60 patients diagnosed with shoulder impingement syndrome were selected from the clinics

Randomized, controlled trial of intraven
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
✍ Gil I. Wolfe; Richard J. Barohn; Barbara M. Foster; Carlayne E. Jackson; John T. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We initiated a randomized, double‐blinded, placebo‐controlled trial of intravenous immunoglobulin (IVIG) treatment in myasthenia gravis (MG). Patients received IVIG 2 gm/kg at induction and 1 gm/kg after 3 weeks vs. 5% albumin placebo. The primary efficacy measurement was the change in